Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
3.800
-0.170 (-4.28%)
At close: May 11, 2026, 4:00 PM EDT
3.700
-0.100 (-2.63%)
After-hours: May 11, 2026, 6:27 PM EDT
Whitehawk Therapeutics Employees
Whitehawk Therapeutics had 23 employees as of December 31, 2025. The number of employees decreased by 17 or -42.50% compared to the previous year.
Employees
23
Change
-17
Growth
-42.50%
Revenue / Employee
n/a
Profits / Employee
-$5,035,043
Market Cap
187.83M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 23 | -17 | -42.50% |
| Sep 30, 2025 | 22 | -31 | -58.49% |
| Jun 30, 2025 | 21 | -49 | -70.00% |
| Mar 31, 2025 | 18 | -57 | -76.00% |
| Dec 31, 2024 | 40 | -49 | -55.06% |
| Sep 30, 2024 | 53 | -35 | -39.77% |
| Jun 30, 2024 | 70 | -19 | -21.35% |
| Mar 31, 2024 | 75 | -5 | -6.25% |
| Dec 31, 2023 | 89 | 10 | 12.66% |
| Sep 30, 2023 | 88 | 12 | 15.79% |
| Jun 30, 2023 | 89 | 22 | 32.84% |
| Mar 31, 2023 | 80 | 26 | 48.15% |
| Dec 31, 2022 | 79 | 40 | 102.56% |
| Sep 30, 2022 | 76 | 55 | 261.90% |
| Jun 30, 2022 | 67 | 57 | 570.00% |
| Mar 31, 2022 | 54 | 44 | 440.00% |
| Dec 31, 2021 | 39 | 31 | 387.50% |
| Sep 30, 2021 | 21 | 13 | 162.50% |
| Mar 31, 2021 | 10 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 293 |
| Karyopharm Therapeutics | 228 |
| Tonix Pharmaceuticals Holding | 142 |
| Caribou Biosciences | 97 |
| Precision BioSciences | 68 |
| InflaRx | 65 |
| Corbus Pharmaceuticals Holdings | 36 |
| Enlivex | 34 |
WHWK News
- 3 days ago - Whitehawk Therapeutics price target raised to $7 from $6 at Oppenheimer - TheFly
- 4 days ago - Whitehawk Therapeutics reports Q1 EPS (32c), consensus (33c) - TheFly
- 4 days ago - Whitehawk Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights - PRNewsWire
- 21 days ago - Whitehawk announces presentation of new preclinical data across ADC portfolio - TheFly
- 22 days ago - Whitehawk Therapeutics Presents Comprehensive Preclinical Data Highlighting its Next-Generation ADC Portfolio at the AACR 2026 - PRNewsWire
- 25 days ago - Whitehawk Therapeutics to Participate in Jones Trading Post-AACR Fireside Chat Series - PRNewsWire
- 25 days ago - Whitehawk Therapeutics management to meet with Oppenheimer - TheFly
- 25 days ago - Whitehawk Therapeutics initiated with an Outperform at Citizens - TheFly